Proceedings · Session S-399 · filed November 19, 2026
Research Funding & PolicySession paper
Ghana sets four-year evidence drive on commercial health
Ghana’s NIHR-funded ACCORD project will combine modeling, policy engagement and community evidence on five commercial areas, with policy-strengthening goals by 2028.
By Amara Osei4 min read773 words
Summary
- ACCORD is a four-year, multicountry project funded by the National Institute for Health and Care Research.
- The project uses four research approaches: literature review, economic modeling, policy engagement and community evidence gathering.
- Five commercial areas are in scope: tobacco, alcohol, unhealthy food, sugar-sweetened beverages and fossil-fuel-related activities.
- Civil society organisations and residents will submit photographs and other documentation of commercial practices.
- The project targets a Ghana-specific evidence base and stronger national policy development by 2028.
By Amara Osei
A four-year, multicountry research project will give Ghana a nationwide evidence-gathering exercise on commercial influences over public health, health policy and equity, particularly for non-communicable diseases. The initiative will mobilise civil society organisations, community groups and public health advocates, with evidence intended to strengthen national policy by 2028.
The initiative, called Addressing the Commercial Determinants of Health in Sub-Saharan Africa, or ACCORD, forms part of a four-year research program funded by the National Institute for Health and Care Research. KNUST leads Ghana’s work; Arti Singh, an Associate Professor in its School of Public Health, serves as project lead.
At a Tuesday workshop for civil society organisations in Accra, Singh said the exercise addresses a shortage of locally generated evidence about how commercial actors affect health outcomes and policymaking. “This project will generate evidence relevant to the realities of populations in low- and middle-income countries,” she said.
Singh said much of the existing work on commercial determinants of health comes from high-income countries. African countries need evidence generated under their own market, policy and health conditions if interventions are to reflect local circumstances.
How will Ghana collect the evidence?
Four complementary approaches define the project’s research workflow:
- Review existing literature.
- Build economic models.
- Engage with policy.
- Collect community-level evidence.
Under the community strand, civil society organisations and residents will submit information and evidence about commercial activities observed where they live. Participants will photograph and otherwise document marketing, industry sponsorships, promotional campaigns and other practices that may alter consumption patterns.
“Participants would use photographs and other forms of documentation to capture activities such as the marketing of unhealthy products, industry sponsorships, promotional campaigns and other practices that could influence consumption patterns,” Singh said.
This crowdsourcing component will examine five areas: tobacco, alcohol, unhealthy food, sugar-sweetened beverages and fossil-fuel-related activities. The project defines commercial determinants as the systems, practices and pathways through which commercial actors influence people’s health and health equity.
The method links five commercial areas to four research approaches. That breadth could expose common regulatory mechanisms, although the source provides no evidence yet that the gathered material represents Ghana’s population or commercial geography evenly.
Which commercial practices are under scrutiny?
Peter Agyei-Baffour, Dean of KNUST’s School of Public Health, said individual choices have become a major public-health concern because food prices and marketing shape them. He cited billboards for sugary drinks near schools, plus television and social media promotion, as concerns requiring attention.
His examples identify exposure points, but they do not establish campaign reach, purchasing effects or differences in consumption by income or age. Those measurements would be necessary before managers could judge whether a proposed intervention would change behaviour rather than merely reduce visibility.
Labram Musah, Executive Director of Vision for Accelerated Sustainable Development, said commercial actors have become more sophisticated at influencing public opinion, policymakers and public-health debates. He said some industries use corporate donations, sponsorships, employment-related arguments and community-support initiatives to improve their public image while diverting attention from potential health consequences.
Musah called on civil society organisations to document those practices and produce credible evidence for stronger regulation. He also asked participants to monitor commercial activity in their communities and contribute evidence intended to hold industries accountable.
What could change by 2028?
Singh expects the findings to establish a Ghana-specific evidence base, identify regulatory gaps and guide advocacy for stronger public-health policies. Musah expects the project to support national policy development, contribute to international discussions and improve civil society engagement by 2028.
Those are outputs, not demonstrated outcomes. The announcement does not report a completed study, a health result or a policy adoption. It also gives no grant amount, named participating countries, sampling frame, target number of submissions, model assumptions, verification protocol or criteria for deciding which community reports enter the final evidence base.
That omission limits budget and portfolio review. A four-year grant without a disclosed value prevents comparison of economic-model capacity against field collection, documentation and policy-engagement costs. It also leaves funders unable to assess whether the four workstreams have defined handoffs, quality controls and common measures.
The source does not explain how literature synthesis, economic modeling, policy engagement and crowdsourced evidence will converge. Without a stated integration method, the project could produce parallel products rather than a traceable evidence chain for regulators.
If the community evidence, modeling and policy work converge, ACCORD could give Ghana a defensible basis for stronger controls by 2028. If they do not, the project will have generated documentation, not demonstrated health gains.
via ghanabusinessnews.com (Source)
Filed under
- commercial-determinants-of-health
- public-health-policy
- ghana
- research-funding
- community-engagement
More from Amara Osei
Show full bio
News editor covering money, funding and market shifts around research and development at Hypothesis Wire.
261 articles
References
- Ghana urges ITU to target last-mile connectivity as half of Africa stays offline
- 2026 Access to Medicine Index: Africa's Three Biggest Markets Left Off Access Plans
- Ghana offers Africa an Article 6 model built on 34,705 ITMOs
- Nigerian Trust in Science Stalls at 15 Per Cent, 11 Points Below 2018
- Lancet Analysis Maps Africa's Vaccine R&D Gaps